Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20)
The summary for the Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20): The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions with expertise and innovative strategies for developing research and mentoring opportunities for undergraduate students from backgrounds underrepresented in biomedical research to submit applications for 6 month planning grants for the NIH Building Infrastructure Leading to Diversity (BUILD) initiative. The BUILD initiative aims to increase the diversity of the NIH-funded workforce by supporting collaborative programs that include novel approaches for enhancing undergraduate education, training, and mentorship, as well as infrastructure support and faculty development to facilitate those approaches. BUILD planning grants are intended to help institutions develop the necessary partnerships and infrastructure needed to be competitive for the BUILD initiative.
Federal Grant Title: | Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-RM-13-001 |
Type of Funding: | Grant |
CFDA Numbers: | 93.310 |
CFDA Descriptions: | Trans-NIH Research Support |
Current Application Deadline: | May 10, 2013 |
Original Application Deadline: | May 10, 2013 |
Posted Date: | Mar 07, 2013 |
Creation Date: | Mar 07, 2013 |
Archive Date: | Jun 10, 2013 |
Total Program Funding: | $3,000,000 |
Maximum Federal Grant Award: | $150,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research ...
- • Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabri...
- • Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allow...
- • Short Courses to Promote the Broad and Rigorous Use of Common Fund Data (R25 Clinical Tria...
- • IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (...
- • Using Metabolomics to Investigate Biological Pathways and Networks (R01)
- • Assay Development for High Throughput Molecular Screening (R21)
- • Membrane Protein Production and Structure Determination (R01)
- More Grants from the National Institutes of Health
- • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...